Cargando…
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines
Patients with heart failure (HF) and associated chronic kidney disease (CKD) are a population less represented in clinical trials; additionally, subjects with more severe estimated glomerular filtration rate reduction are often excluded from large studies. In this setting, most of the data come from...
Autores principales: | Beltrami, Matteo, Milli, Massimo, Dei, Lorenzo Lupo, Palazzuoli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025648/ https://www.ncbi.nlm.nih.gov/pubmed/35456336 http://dx.doi.org/10.3390/jcm11082243 |
Ejemplares similares
-
The Role of the Left Atrium: From Multimodality Imaging to Clinical Practice: A Review
por: Beltrami, Matteo, et al.
Publicado: (2022) -
Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting
por: Beltrami, Matteo, et al.
Publicado: (2021) -
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
por: Palazzuoli, Alberto, et al.
Publicado: (2023) -
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
por: Palazzuoli, Alberto, et al.
Publicado: (2023) -
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
por: Palazzuoli, Alberto, et al.
Publicado: (2022)